Research

  • MRI could be key to understanding impact gluten free diet has on people with coeliac disease

    Experts have used magnetic resonance imaging (MRI) to better understand the impact a gluten free diet has on people with coeliac disease, which could be the first step towards finding new ways of treating the condition. Coeliac disease is a chronic condition affecting around one person in every 100 in the general population. When people [...]

  • New brain mapping technique reveals insights into brain’s higher functions

    A new way of mapping activity and connections between different regions of the brain has revealed new insight into how higher order functions like language, thought and attention are organised.  The technique could one day be used to identify pre-clinical symptoms of neurodegenerative diseases such as Alzheimer's. Traditional models of human brain activity represent interactions [...]

  • Report reveals sales surge for UK health manufacturers

    New figures have revealed a dramatic uplift in sales revenue and purchasing for UK health manufacturers. Small and mid-sized firms saw their average sales jump by 121 per cent in the third quarter of this year, while the number of purchase orders (POs) placed with suppliers was also up by 92 per cent, according to [...]

  • Finding that heart has its own ‘brain’ could lead to new treatments for heart disease

    New research from Sweden and the US shows that the heart has a mini-brain – its own nervous system that controls the heartbeat. A better understanding of this system, which is much more diverse and complex than previously thought, could lead to new treatments for heart diseases. The heart has long been thought to be [...]

  • Collaboration to accelerate drug discovery for life saving therapies

    A new collaboration is set to identify and advance cutting-edge scientific findings into new therapies - with a special focus on critical unmet medical needs. The collaboration between USC and Autobahn Labs, an accelerator for early-stage drug discovery, will see Autobahn invest up to $5 million per selected project to support the development of new [...]

  • Research assesses feasibility of collaborative clinical trials between health tech providers and primary care

    A first-of-its-kind randomised control trial is being conducted across Northumbria to assess the feasibility of carrying out a low-cost collaborative clinical trial using digital interventions to support people with hypertension and depression and/or anxiety.  Over a 12-week period, enrolled patients at Northumbria Primary Care took part in the trial by using Holly Health’s digital coaching [...]

  • Remote medical interpreting ‘may be hindering healthcare communication’

    Remote medical interpreting (RMI) may be hindering healthcare communication rather than helping it, according to a new study from the University of Surrey.   As the healthcare sector leaned heavily on technology during the COVID-19 pandemic, interpreters reported mixed experiences that raises serious questions about the effectiveness of remote communication platforms in critical medical settings. The [...]

  • Heart attacks could be ruled out early with new test, researchers find

    As many as 60 per cent of people presenting to emergency departments around the world with heart attack symptoms could be safely sent home, many at earlier stages, with the support of a new high-sensitivity cardiac troponin test, researchers in the US have found. The assay from global health technology provider Mindray allows clinical teams [...]

  • Space: A new frontier for exploring stem cell therapy

    Stem cells grown in microgravity aboard the International Space Station (ISS) have unique qualities that could one day help accelerate new biotherapies and heal complex disease, two Mayo Clinic researchers say. The research analysis finds microgravity can strengthen the regenerative potential of cells. Dr. Zubair is a laboratory medicine expert and medical director for the [...]

  • Glaucoma drug shows promise against neurodegenerative diseases

    A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in Alzheimer’s disease. Researchers in the UK Dementia Research Institute at the University of Cambridge screened more than 1,400 clinically-approved [...]